IRAE
Clinical trials for IRAE explained in plain language.
Never miss a new study
Get alerted when new IRAE trials appear
Sign up with your email to follow new studies for IRAE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for patients stricken by Immunotherapy's dangerous blood side effects
Disease control Not yet recruitingThis study is testing an experimental drug called golidocitinib for patients with advanced lung cancer. These patients are experiencing severe, hard-to-treat blood-related side effects (like very low blood cell counts) caused by their immunotherapy. The main goal is to see if gol…
Matched conditions: IRAE
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Common drug may shield cancer patients from harsh treatment side effects
Disease control Not yet recruitingThis study is testing if ondansetron, a medicine often used for nausea, can help reduce the harmful side effects caused by powerful immunotherapy drugs used to treat liver cancer. It will involve 66 patients who are scheduled to receive standard immunotherapy. Researchers will co…
Matched conditions: IRAE
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Mar 05, 2026 13:59 UTC